Related Articles
Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07
Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation
Effect of IFN-β on human glioma cell lines with temozolomide resistance
O6-methyl-guanine-DNA methyltransferase methylation and IDH1/2 mutation in small cell lung cancer
Rechallenge with temozolomide with different scheduling is effective in recurrent malignant gliomas